VYVGART Hytrulo prefilled syringe for self-injection (single-dose subcutaneous injection: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase) has been approved by the U.S. FDA for the treatment of adults with anti-AChR antibody-positive generalized myasthenia gravis (gMG). The VYVGART Hytrulo prefilled syringe is a self-injection that takes about 20-30 seconds.* It is injected under the skin (subcutaneously). Patients and/or their caregivers will receive in-person… Read more »
Posts Categorized: blog
Vaccination & MG: What You Should Know
By Raghav Govindarajan, Neurologist and Conquer MG Medical Advisory Board Member What is a vaccine? Vaccination is a safe, and effective way of protecting you or your loved one against harmful diseases. It uses your body’s natural defenses to build resistance to specific infections and makes your immune system stronger. How do vaccines work? … Read more »
Conquer MG Ambassadors Travel To Washington, DC for Rare Disease Week
Rare Disease Week is a multi-day event, hosted by the Rare Disease Legislative Advocates (a program of the EveryLife Foundation for Rare Diseases), that brings together rare disease advocates from across the country to make their voices heard. Participants are educated on policy proposals impacting the rare disease community and provided opportunities to advocate for… Read more »
